Keyphrases
Genome Variation
100%
Single nucleotide Polymorphism
100%
Infection Risk
100%
Induction Treatment
100%
Childhood Acute Lymphoblastic Leukemia
100%
Host Genome
100%
Host Genomics
50%
Positive Blood Culture
50%
Induction Therapy
50%
Downstream Signaling
25%
Classification and Regression Tree
25%
Bile Salts
25%
CCL11
25%
MHC Class I
25%
Acute Lymphoblastic Leukemia
25%
Immune Function
25%
Classification Tree Analysis
25%
Pharmacogenomics
25%
Leukemia Patients
25%
Neutrophil Count
25%
Metabolism
25%
G Protein-coupled Receptor
25%
Antigen Presentation
25%
Genomic Profiling
25%
Genomic Variation
25%
Hazard Ratio
25%
Regression Tree Analysis
25%
Antigen Processing
25%
Path Analysis
25%
Supportive Care
25%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Infection
100%
Genome Variation
100%
Single Nucleotide Polymorphism
80%
Antigen Presentation
40%
Blood Culture
40%
Bile Salt
20%
Neutrophil
20%
Hazard Ratio
20%
Bile Acid
20%
Immune Function
20%
G Protein Coupled Receptor
20%
Supportive Care
20%
Biochemistry, Genetics and Molecular Biology
Single-Nucleotide Polymorphism
100%
Genome Variation
100%
Antigen Presentation
50%
Genomics
50%
Bile Acid
25%
CCL11
25%
Metabolic Pathway
25%
MHC Class I
25%
G Protein Coupled Receptor
25%
Pharmacogenomics
25%
Immunity
25%
Neutrophil Count
25%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Acute Lymphoblastic Leukemia
100%
Bile Salt
20%
Bile Acid
20%
G Protein Coupled Receptor
20%
Pharmacogenomics
20%
Immunology and Microbiology
Single Nucleotide Polymorphism
100%
Antigen Presentation
50%
Pharmacogenomics
25%
CCL11
25%
Neutrophil Count
25%
Immunity
25%
MHC Class I
25%